Abstract
The kinetics of oxidation of the HMG-CoA reductase inhibitors lovastatin, simvastatin, L-157,012, and L-647,318 were studied in an aqueous surfactant solution. A thermally labile free radical initiator was used to attain measurable reaction rates at 40°C and rate constants were determined by measuring oxygen consumption using an oxygen electrode. The stability of the drugs was found to increase in the order lovastatin = simvastatin < L-157,012 < L-647,318. The addition of butylated hydroxyanisole (BHA) was found to stabilize the drugs. For the oxidation of lovastatin, the effectiveness of antioxidants increased in the order propyl gallate < BHA < alpha-tocopherol. It is concluded that the stability of oxidizable drugs can be rapidly and conveniently assessed by the techniques described herein.
Similar content being viewed by others
REFERENCES
R. A. Sheldon and J. K. Kochi. Metal-Catalyzed Oxidations of Organic Compounds, Academic Press, New York, 1981.
J. J. Krukemyer and R. L. Talbert. Pharmacotherapy 7:198–210 (1987).
R. Battino and E. Wilhelm. Chem. Rev. 73:1–9 (1973).
J. A. Howard. In G. H. Williams (ed.), Advances in Free-Radical Chemistry, Vol. IV, Academic Press, New York, 1972, pp. 49–173.
J. A. Howard and K. U. Ingold. Can. J. Chem. 41:2800–2806 (1963).
L. R. Mahoney. Angew. Chem., Int. Ed. Engl. 8:547–555 (1969).
APA. Handbook of Pharmaceutical Excipients, American Pharmaceutical Association, Washington, D.C., 1986.
G. W. Burton and K. U. Ingold. J. Am. Chem. Soc. 103:6472–6477 (1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kaufman, M.J. Applications of Oxygen Polarography to Drug Stability Testing and Formulation Development: Solution-Phase Oxidation of Hydroxymethylglutaryl Coenzyme A (HMG-CoA) Reductase Inhibitors. Pharm Res 7, 289–292 (1990). https://doi.org/10.1023/A:1015886415210
Issue Date:
DOI: https://doi.org/10.1023/A:1015886415210